When Rare Communities Organize,
Medicine Changes Forever.

For decades, "rare" meant invisible — too few patients for research, too little data for progress, too much isolation for hope.

That story is being rewritten.

Across the globe, visionary patient communities have built structured registries, shared data responsibly, partnered with clinicians, and driven real-world breakthroughs. The results speak for themselves: doubled life expectancy, multiple new therapies approved in record time, and families who finally feel seen and empowered.

These six stories are not exceptions. They are blueprints.

Your community could be next.

Rare Disease Community Success Stories

  • Cystic Fibrosis Community

    Patient Registry + Continuous Data Feedback
    1986 National Patient Registry launched
    1989 CFTR gene discovered
    2012 First CFTR modulator approved
    2019 Trikafta transforms outcomes for 90% of patients
    • Identified care variations leading to quality improvement programs
    • Genotype-specific drug development
    • Median survival rose from approximately 30 to over 50 years
    Core Lesson When patients consent to structured, longitudinal data collection, and that data is continuously analyzed and fed back into care systems, measurable outcomes improve.
    Visit CF Foundation Registry (opens in new tab)

  • Duchenne Muscular Dystrophy (DMD) Community

    Global Registries + Advocacy-Driven Research
    2000s Parent Project Muscular Dystrophy & TREAT-NMD registries
    2010s Natural history studies define progression
    2021+ Multiple exon-skipping therapies approved
    Core Lesson Natural history data becomes essential infrastructure. Patient organizations played a central coordinating role.
    Visit Parent Project Muscular Dystrophy (opens in new tab)

  • Rare Genomic Disorders & Matchmaking Networks

    Undiagnosed Diseases Network (UDN) & Gene Matching
    2015 UDN launched
    2017+ Matchmaker Exchange goes global
    2020s Dozens of new gene-disease associations discovered
    Core Lesson Ultra-rare does not mean isolated. Structured data sharing under ethical governance changes everything.
    Visit Undiagnosed Diseases Network (opens in new tab)

  • ALS Community

    Open Data and Rapid Trial Frameworks
    2010s ALS Therapy Development Institute & PRO-ACT database
    2022 Expanded access & real-world evidence pathways
    Core Lesson Patients are informed participants who contribute valuable data and lived experience insight.
    Visit ALS Association (opens in new tab)

  • Global Rare Disease Registries

    Patient-Owned Data Frameworks (NORD IAMRARE, etc.)
    2010s NORD IAMRARE platform launch
    2020s 50+ disease-specific registries now research-ready
    Core Lesson Infrastructure changes visibility. When a condition has a registry, it becomes measurable — and researchable.
    Visit NORD (opens in new tab)

  • Spinal Muscular Atrophy (SMA) Community

    Patient Registries + Newborn Screening Advocacy + Rapid Therapy Translation
    1984 Cure SMA (Families of SMA) founded
    2008 International SMA Registry established
    2016 Spinraza — first therapy approved
    2019 Zolgensma gene therapy approved
    2020 Evrysdi (oral) approved
    2023 Newborn screening in 48+ U.S. states
    • Three disease-modifying therapies in under 5 years
    • Type 1 SMA mortality dramatically reduced
    • Many children now achieve motor milestones once impossible
    Core Lesson When patient organizations combine robust data infrastructure with bold policy advocacy, they can turn a once-fatal childhood disease into a manageable condition in a single generation.
    Visit Cure SMA (opens in new tab)

You are cordially invited

Your Story Matters

Whether you carry a rare diagnosis, love someone who does, or simply wish to learn more — we would be honoured to hear from you.

Accept This Invitation